Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
11/2005
11/02/2005CN1690047A 9-substituted minocycline compounds
11/02/2005CN1690046A Improved process for synthesizing L-theanine
11/02/2005CN1225471C Compounds with growth hormone releasing properties
11/01/2005US6960588 Tryptase inhibitors
11/01/2005US6960355 Modified amino acid compounds useful in delivery of active agents
10/2005
10/27/2005WO2005100325A1 Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors
10/27/2005WO2005054168A3 A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide
10/27/2005WO2004016213A3 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
10/27/2005US20050239896 A 5-(2,3,5,6-tetrafluoro-4-trifluoromethyl-benzylamino)-benzoic acid, acid ester, sulfonic acid or amide derivatives, for treating Alzheimer's disease, Parkinson's disease and Huntington's disease, epilepsy, stroke, depression, glaucoma
10/27/2005US20050239870 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; aminoalkylamide, piperidine-, indole-, or pyrrole-amide derivatives; anticarcinogenic agents
10/27/2005US20050239849 Substituted phenoxyacetic acids
10/27/2005US20050239828 Spirocyclic amides as cannabinoid receptor modulators
10/27/2005US20050239790 Substituted hydroxyethylamine aspartyl protease inhibitors
10/27/2005US20050238615 Process for the production of dendritic trimesic acid triamides
10/26/2005EP1589000A2 (R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
10/26/2005EP1587796A1 Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands
10/26/2005EP1587527A1 Amino acid derived prodrugs of propofol, compositions and uses thereof
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005CN1224609C Process for preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties
10/25/2005USRE38856 with ultra low salt content; from a highly acidic hot triiodination by increasing the pH with a base, adding seed crystals, cooling slowly, and washing the collected precipitate; making iohexol for example
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/20/2005WO2005058845A3 Novel glucagon antagonists/inverse agonists
10/20/2005US20050234232 Novel compositions for the delivery of negatively charged molecules
10/20/2005US20050234126 Amide derivatives as inhibitors of the enzymatic activity of renin
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050233398 Lidocaine analogs and methods of making and using same
10/19/2005EP1585752A1 Polyene polyketides, processes for their production and their use as a pharmaceutical
10/19/2005CN1682702A Method for preparing medicine composition capable of inhibiting post infective virus proteinase
10/18/2005US6956988 Optical interleaver
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005US6955888 Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
10/18/2005CA2156288C Glycerol derivative, device and pharmaceutical composition
10/13/2005WO2005095343A1 Dpp-iv inhibitors
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005065315A3 Bone targeting compounds for delivering agents to the bone for interaction therewith
10/13/2005US20050228033 Voltage-gated sodium channel (VGSC) and prostate voltage sodium channel (PVSC) inhibitors for treating diseases characterized by overabundant or hyperactive VGSC/PVSC's; phenytoin derivatives; use as sodium channel blockers, anti-cancer agents; can be used to limit or prevent PSA growth and metastasis
10/13/2005US20050227990 Aminoalkoxy-functional chalcones
10/13/2005US20050227982 Antileishmanial dinitroaniline sulfanomides with activity against parasite tubulin
10/13/2005US20050227288 Synthesis and application of procainamide analogs for use in an immunoassay
10/13/2005CA2558446A1 Dpp-iv inhibitors
10/12/2005EP1583726A2 Activity-based probes, and methods of their preparation and use
10/12/2005CN1680314A 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/12/2005CN1680292A Compounds useful as intermediates of 4-aminoquinoline deravative
10/12/2005CN1222501C Novel compounds
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953812 Carboxy and amide containing compound suitable for treatment and/or prevention of diseases wherein a glucagon antagonistic action is beneficial, such as hyperglycemia, diabetes, disorders of the lipid metabolism, such as dyslipidemia
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/06/2005WO2005092899A1 Inhibitors of histone deacetylase
10/06/2005WO2005092848A1 Novel perfluoroalkyl hydrophobic and oil-repellent surfactants derived from substituted amides, preparation and use thereof
10/06/2005WO2005092841A1 Compounds having beta-agonist activity
10/06/2005WO2005092840A1 Formamide derivatives useful as adrenoceptor
10/06/2005WO2005092839A1 A novel catalytic process for the production of 3,3', 4,4'-tetraminobiphenyl
10/06/2005WO2005092011A2 Mitotic kinesin inhibitors
10/06/2005WO2005073216A3 Hcv ns-3 serine protease inhibitors
10/06/2005WO2005055928A3 Zn2+ -chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors
10/06/2005US20050222395 New peptide derivatives
10/06/2005US20050222243 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/06/2005US20050222231 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; nervous system, psychological, and psychiatric disorders
10/06/2005CA2560368A1 Compounds for the treatment of diseases
10/06/2005CA2560213A1 Mitotic kinesin inhibitors
10/06/2005CA2559733A1 Inhibitors of histone deacetylase
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581476A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
10/05/2005EP1581467A2 Ligands for metals and improved metal-catalyzed processes based thereon
10/05/2005CN1678566A Novel composition containing acyl group
10/05/2005CN1221527C Novel crystal of stilbene derivative and process for producing the same
10/05/2005CN1221524C Diphenyl ether compounds useful in therapy
10/04/2005US6951955 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
10/04/2005US6951889 7-acetamidinyl derivatives
10/04/2005US6951884 Fluorobenzamides and uses thereof
10/04/2005US6951878 Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases)
10/04/2005CA2238275C Metalloproteinase inhibitors
09/2005
09/29/2005WO2005090305A1 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension
09/29/2005WO2005090302A2 Palladium catalyzed indolization of 2-bromo or chloroanilines
09/29/2005WO2005090288A1 Phenylaminoethanol derivates as beta2 receptor agonists
09/29/2005WO2005090287A2 Phenylethanolamine derivatives as beta-2 agonists
09/29/2005WO2005090284A1 Non-glycosylated/non-glycosidic/non-peptidic small molecule psgl-1 mimetics for the treatment of inflammatory disorders
09/29/2005WO2005089815A2 Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
09/29/2005WO2005073195A3 Hcv ns-3 serine protease inhibitors
09/29/2005US20050215825 Hydroaminomethylation of an olefin, a primary or secondary amine with a catalyst of a neutral rhodium-monodentate phosphite ligand complex prepared by contacting a neutral rhodium procatalyst with a monodentate phosphite ligand; chemical intermediate for ibutilide, terfenadine, and fexofenadine
09/29/2005US20050215823 Novel catalytic process for the production of 3,3', 4,4'-tetraminobiphenyl
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215598 Phenylalanine derivatives
09/29/2005US20050215590 Formamide derivatives for the treatment of diseases
09/29/2005US20050215587 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
09/29/2005US20050215532 Tetracycline compounds for treatment of cryptosporidium parvum related disorders
09/29/2005US20050214853 Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter
09/29/2005US20050214828 Using ultrviolet laser excitation and fluorescence to identify regions of hybridization along microarray comprised of immobilized polynucleotides; gene expression analysis; genomics
09/29/2005DE10333042B4 Verfahren zur Herstellung von cyclischen Phosphonsäureanhydriden und deren Verwendung A process for preparing cyclic phosphonic anhydrides and their use
09/29/2005DE102004011720A1 Radiohalogenierte Benzamidderivate und deren Verwendung in der Tumordiagnostik und Tumortherapie Radio Halogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
09/29/2005CA2560199A1 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension
09/29/2005CA2559533A1 Phenylaminoethanol derivatives as beta2 receptor agonists
09/29/2005CA2559203A1 Phenylethanolamine derivatives as beta-2 agonists
09/29/2005CA2558051A1 Palladium catalyzed indolization of 2-bromo or chloroanilines
09/28/2005EP1580185A1 Secondary n-Alkylhydroxylated p-Phenylendiamins, dye composition for keratin fibers containing them, processes and uses.
09/28/2005EP1578898A2 Nad synthetase inhibitors and uses thereof
09/28/2005EP1578719A2 Stereoisomers of p-hydroxy-milnacipran, and methods of use thereof
09/28/2005EP1578359A2 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof
09/28/2005CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 162